4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-018223
Director sold 40,000 shares at an average $97.60 ($3,903,914)
- Director acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KUEBLER CHRISTOPHER A Director | 2018-03-06 | Option exercise | +2,600 | $5.14 | $13,364 | 43,100 | D |
| KUEBLER CHRISTOPHER A Director | 2018-03-06 | Sale | −2,600 | $100.30 | $260,780 | 40,500 | D |
| KUEBLER CHRISTOPHER A Director | 2018-03-07 | Option exercise | +27,400 | $5.14 | $140,836 | 67,900 | D |
| KUEBLER CHRISTOPHER A Director | 2018-03-07 | Option exercise | +10,000 | $9.24 | $92,400 | 77,900 | D |
| KUEBLER CHRISTOPHER A Director | 2018-03-07 | Sale | −37,400 | $97.41 | $3,643,134 | 40,500 | D |
| Derivatives | |||||||
| KUEBLER CHRISTOPHER A Director | 2018-03-06 | Option exercise · Stock Option | −2,600 | 27,400 | D | ||
| KUEBLER CHRISTOPHER A Director | 2018-03-07 | Option exercise · Stock Option | −27,400 | 0 | D | ||
| KUEBLER CHRISTOPHER A Director | 2018-03-07 | Option exercise · Stock Option | −10,000 | 30,000 | D | ||
| Open-market sales · 40,000 sh · avg $97.60 · $3,903,914 | |||||||
Loading xslF345X03/doc4.xml…